European Archives - Page 1116 of 1554 - European Medical Journal

The Digital Legacy of COVID-19

REMOTE communication tools have flourished following the rapid spread of the novel coronavirus, keeping individuals informed and united across the globe…

An Interview with Prof Manish Chand in Lead-up to the International Colorectal Disease Symposium

Speaking to us in the lead-up to the 2020 Israel International Colorectal Disease Symposium, Prof Manish Chand…

Gloves in the Time of Corona

Love in the Time of Cholera, the widely known 1985 novel by one of my favourite authors, Gabriel García Márquez, primarily details the affairs of three main…

COVID-19 Rapid Diagnostic Test Approved by the FDA

RAPID diagnosis of COVID-19 is critical to reduce the spread of the virus to the public and healthcare providers around them.

Bactiguard Starts Manufacturing Disinfectants in Sweden

Bactiguard launched the disinfectant HYDROCYN aqua® in Sweden at the beginning of March and, since then, demand has been high.

CELLINK launches a real-time qPCR instrument

CELLINK has started reselling a qPCR instrument. The instrument uses a laboratory technique of molecular biology based on the polymerase chain reaction…

Vaccines for COVID-19: Perspectives, Prospects, and Challenges Based on Candidate SARS, MERS, and Animal Coronavirus Vaccines

Several coronaviruses (CoV) are widespread in humans and cause only mild upper respiratory infections and colds; however, pandemic outbreaks of more…

Talking to Arpita Pani

GOLD is joined in the studio by Arpita Pani, Senior Commercial Governance, Digital and E-Commerce Lead at Ferring Pharmaceuticals, to discuss the evolution and future of digital marketing in pharma, including the industry’s use of social media.

Will Inhalation Therapy Replace Stem Cell Therapy in Pulmonary Fibrosis?

Will Inhalation Therapy Replace Stem Cell Therapy in Pulmonary Fibrosis?

PULMONARY fibrosis, a life-threatening disease caused by the damaging and scarring of lung tissue, currently has limited treatment options…

COVID-19 Stable on Surfaces for up to 3 Days

COVID-19 Virus Stable on Surfaces for up to 3 Days

THE VIRUS associated to coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…